Dec 11, 2025 · Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated …

10 hours ago · Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research software platform to analyze and …

Dec 26, 2025 · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

2 days ago · Shares of Illumina, Inc. (NASDAQ:ILMN - Get Free Report) have earned an average recommendation of "Hold" from the twenty-one brokerages that are covering the company, …

5 days ago · Here’s who holds the biggest stakes in Illumina today and what recent ownership and insider activity suggest about confidence in its long-term growth outlook.

1 day ago · Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Regeneron (REGN Quick Quote REGN - Free Report) and Illumina …

We are Illumina We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to …

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, …

Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.